---
category: listing
circular_id: bc87528c2a8dfe8f
date: '2026-02-25'
description: 'Healthcare Global Enterprises Limited (BSE: 539787) has fixed March
  2, 2026 as the record date for a rights issue offering 1 new equity share for every
  17 shares held at Rs 512/- per share (Rs 10 face value + Rs 502 premium).'
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={03757085-AFB8-4A26-8D26-967A1D2E8D8A}&noticeno=20260225-44&dt=02/25/2026&icount=44&totcount=47&flag=0
impact: high
impact_ranking: high
importance_ranking: high
justification: Rights issue directly affects existing shareholders' holdings and requires
  trading members to execute transactions on an ex-rights basis from the record date,
  with immediate pricing and eligibility implications for all holders.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260225-44&attachedId=
processing:
  attempts: 1
  content_hash: 55bbb09b8e4cc78b
  processed_at: '2026-02-25T19:12:52.974044'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-02-25T17:54:07+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={03757085-AFB8-4A26-8D26-967A1D2E8D8A}&noticeno=20260225-44&dt=02/25/2026&icount=44&totcount=47&flag=0
severity: high
source: bse
stocks:
- HCGL
tags:
- rights-issue
- corporate-actions
- equity
- ex-rights
- healthcare-global-enterprises
- rolling-settlement
title: Rights Issue of Equity Shares of Healthcare Global Enterprises Limited
---

## Summary

Healthcare Global Enterprises Limited (BSE Scrip Code: 539787) has announced a Rights Issue of Equity Shares with a record date of March 2, 2026. Trading in the company's equity shares must be conducted on an Ex-Rights basis effective from March 2, 2026 (Settlement No. DR-831/2025-2026). The issue offers 1 new equity share for every 17 shares held, priced at Rs 512/- per share.

## Key Points

- Company: Healthcare Global Enterprises Limited (BSE Code: 539787)
- Rights ratio: 1 new equity share for every 17 existing equity shares held
- Issue price: Rs 512/- per share (face value Rs 10/- + premium Rs 502/-)
- Record Date: February 28, 2026 (effective ex-rights basis from March 2, 2026)
- Settlement reference: DR-831/2025-2026
- Segment: Dematerialised Securities â€“ Rolling Settlement
- All trading members are instructed to note the ex-rights trading requirement

## Regulatory Changes

No new regulatory changes introduced. This circular implements existing SEBI and BSE framework for rights issue corporate actions, requiring mandatory ex-rights trading from the record date.

## Compliance Requirements

- Trading Members must execute all transactions in Healthcare Global Enterprises Limited equity shares on an Ex-Rights basis with effect from March 2, 2026.
- Members must update their systems and client communications to reflect the ex-rights adjustment.
- Settlement of transactions must reference DR-831/2025-2026 for the relevant period.

## Important Dates

- **Record Date:** March 2, 2026
- **Ex-Rights Trading Effective From:** March 2, 2026
- **Settlement Number:** DR-831/2025-2026
- **Circular Date:** February 25, 2026

## Impact Assessment

Existing shareholders of Healthcare Global Enterprises Limited as of the record date (March 2, 2026) will be entitled to subscribe to 1 new equity share for every 17 shares held at Rs 512/- per share. The rights issue will dilute existing shareholding by approximately 5.88% upon full subscription. Trading members must adjust order entry and pricing from the ex-rights date to avoid settlement mismatches. The premium of Rs 502/- over the Rs 10/- face value reflects the current market valuation of the company. Shareholders who do not subscribe may see proportional dilution of their holdings.